Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Pineal Tumors

  • Author: Jeffrey N Bruce, MD; Chief Editor: Brian H Kopell, MD  more...
 
Updated: Oct 27, 2015
 

Background

The pineal gland develops during the second month of gestation as a diverticulum in the diencephalic roof of the third ventricle. It is flanked by the posterior and habenular commissures in the rostral portion of the midbrain directly below the splenium of the corpus callosum. The velum interpositum is found rostral and dorsal to the pineal gland and contains the internal cerebral veins, which join to form the vein of Galen.

Pineal region tumors are derived from cells located in and around the pineal gland. The principle cell of the pineal gland is the pineal parenchymal cell or pinocyte. This cell is a specialized neuron related to retinal rods and cones. The pinocyte is surrounded by a stroma of fibrillary astrocytes, which interact with adjoining blood vessels to form part of the blood-pial barrier.

The pineal gland is richly innervated with sympathetic noradrenergic input from a pathway that originates in the retina and courses through the suprachiasmatic nucleus of the hypothalamus and the superior cervical ganglion. Upon stimulation, the pineal gland converts the sympathetic input into hormonal output by producing melatonin, which has regulatory effects upon hormones such as luteinizing hormone and follicle-stimulating hormone.

The pineal gland is a neuroendocrine transducer that synchronizes hormonal release with phases of the light-dark cycle by means of its sympathetic input. However, the exact relationship between the pineal gland and human circadian rhythm remains unclear and is an active area of investigation.

Some images of pineal tumors are below.

Gadolinium-enhanced MRI of a 33-year-old woman who Gadolinium-enhanced MRI of a 33-year-old woman who presented with visual loss, amenorrhea, and diabetes insipidus. MRI shows germinomatous invasion of the pineal gland (large arrowhead), optic chiasm (long arrow), pituitary stalk (small arrowhead), and floor of the third ventricle (short arrow).
Noncontrast MRI of a pineocytoma in a 40-year-old Noncontrast MRI of a pineocytoma in a 40-year-old man presenting with acute hydrocephalus. At surgery, the high signal area (arrow) turned out to be acute hemorrhage.
MRI of a 21-year-old man with a germinoma in the p MRI of a 21-year-old man with a germinoma in the pineal region. This T1-weighted noncontrast sagittal scan shows isointense tumor, which has obstructed the aqueduct of Sylvius (arrow) to cause hydrocephalus.
Next

History of the Procedure

In the early part of the 20th century, pineal region surgery had poor outcomes, with operative mortality rates approaching 90%. From Horsley's initial attempt at removing a pineal mass in 1910 through the development of the lateral transventricular approach in 1931 by Van Wagenan, primitive anesthetic technique and the lack of an operating microscope hindered pineal region surgery.[1]

In 1948, Torkildsen argued for abandoning aggressive surgical resection in favor of cerebrospinal fluid (CSF) diversion followed by empiric radiotherapy.[2] If the patient did not respond to radiation, a surgical procedure to remove radioresistant tumor was performed. The algorithm of CSF diversion, radiation, and observation sometimes was successful; however, patients with benign lesions were exposed to unnecessary and ineffective radiation.

Modification of this treatment strategy led to the radiation test heralded by Japanese clinicians whose patient population had an inordinately high percentage of radiosensitive germinomas. According to this protocol, patients were administered small doses of radiation, and their cases were followed radiologically. Pineal tumors that decreased in size were presumed to be radiosensitive, and a full course of radiation was instituted. Patients not responding to radiotherapy underwent surgical exploration. Despite the low dose of radiation initially used, significant long-term morbidity remained associated with this strategy, particularly in children.

The advent of microsurgical techniques and stereotactic procedures in the later part of the 20th century has obviated the need for empiric radiotherapy without tissue diagnosis. Therapeutic decision-making now is based on tumor histology rather than radiation responsiveness. Currently, initial surgical management for tissue diagnosis, and possible resection, is the standard of care for most children with pineal region tumors.

Previous
Next

Problem

Initial management of patients with pineal region tumors should be directed at treating hydrocephalus and establishing a diagnosis. Preoperative evaluation should include (1) high-resolution MRI of the head with gadolinium; (2) measurement of serum and CSF markers, if available; (3) cytologic examination of CSF, if available; (4) evaluation of pituitary function if endocrine abnormalities are suspected; and (5) visual field examination if suprasellar extension of the tumor is noted on MRI. The ultimate management goal should be to refine adjuvant therapy based on tumor pathology.

Previous
Next

Epidemiology

Frequency

Pineal region tumors make up 0.4-1.0% of intracranial tumors in adults and 3.0-8.0% of brain tumors in children. Most children are aged 10-20 years at presentation, with the average age at presentation being 13 years. Adults typically are older than 30 years at presentation. A complete differential diagnosis for masses in the pineal region also should include vascular anomalies, as well as metastatic tumor.

Previous
Next

Etiology

Tumors of the pineal region have a varied histology that generally can be divided into germ cell and non–germ cell derivatives. Most tumors are a result of displaced embryonic tissue, malignant transformation of pineal parenchymal cells, or transformation of surrounding astroglia. No specific genetic mutations have been associated with sporadic pineal region tumors.

Previous
Next

Pathophysiology

The pathophysiology of pineal region tumors is mostly a result of anatomic compression of adjacent structures, although local infiltration of neural structures can lead to symptoms in cases of highly invasive tumors. In some cases, neuroendocrine dysfunction is precipitated by specific factors secreted by the tumor. The clinical correlates of this pathophysiology are described in the following section on clinical presentation.

Previous
Next

Presentation

The clinical syndromes associated with pineal region tumors relate directly to normal pineal anatomy, as well as tumor histology.

Mass lesions in the pineal region that compress adjacent structures result in typical clinical syndromes. One of the most common presentations is headache, nausea, and vomiting caused by aqueductal compression and resultant obstructive hydrocephalus. Untreated, hydrocephalus may lead progressively to lethargy, obtundation, and death.

Compromise of the superior colliculus, either through direct compression or through tumor invasion, results in a syndrome of vertical gaze palsy that can be associated with pupillary or oculomotor nerve paresis. This eponymic syndrome was first described by the French ophthalmologist Henri Parinaud in the late 1800s and has become virtually pathognomonic for lesions involving the quadrigeminal plate.

Further compression of the periaqueductal gray region may cause mydriasis, convergence spasm, pupillary inequality, and convergence or refractory nystagmus. Impairment of downgaze becomes more pronounced with tumors involving the ventral midbrain. Patients also can present with motor impairment, such as ataxia and dysmetria, resulting from compromise of cerebellar efferent fibers within the superior cerebellar peduncle.

Children with pineal region tumors can present with endocrine malfunction. Hydrocephalus or concurrent suprasellar tumors can cause diabetes insipidus. More specific endocrine syndromes can arise from secretion of hormones by germ cell tumors. Pseudoprecocious puberty caused by beta human chorionic gonadotropin (bhCG) can be observed with germ cell tumors in either the pineal or suprasellar region. In a large series of patients with germ cell tumors and suprasellar involvement, 93% of girls older than 12 years had secondary amenorrhea and 33% of patients younger than 15 years had growth arrest.

Pineal apoplexy, bleeding into the tumor area, has been described as a rare presenting feature of pineal region tumors. Hemorrhage into a vascular-rich pineal tumor can occur preoperatively and is a well-described postoperative complication.

Previous
Next

Indications

Indications for neurosurgical intervention relate to the severity and chronicity of clinical presentation. The symptoms of pineal region tumors can be as varied as their diverse histology. Prodromal periods can last from weeks to years. Therefore, a rigorous and uniform preoperative workup is a requisite for all patients thought to harbor a pineal region tumor.

Any endocrine abnormalities should be investigated prior to surgery. Patients presenting with signs and symptoms of raised intracranial pressure must receive a head CT scan or an MRI to assess the need for emergent management. Subsequent nonemergent workup of a patient with a pineal region tumor can be divided into radiologic and laboratory studies.

Previous
Next

Relevant Anatomy

In their 1954 pineal tumor study, Ringertz and colleagues defined the pineal region as being bound by the splenium of the corpus callosum and tela choroidea dorsally, the quadrigeminal plate and midbrain tectum ventrally, the posterior aspect of the third ventricle rostrally, and the cerebellar vermis caudally.[3] As discussed in the subsequent section on treatment of these lesions, important anatomic considerations include the presence of deep venous structures.

Previous
Next

Contraindications

Relatively few contraindications specifically preclude the surgical treatment of pineal region tumors. Medical clearance for general anesthesia is a requisite, as well as preoperative evaluation of neck motion (ie, tolerance of flexion) prior to planning a supracerebellar/infratentorial approach.

Previous
Next

Prognosis

In a study of 35 consecutive patients from 7 academic centers of the Rare Cancer Network diagnosed between 1988 and 2006 (median age, 36 yr), median disease-free survival was 82 month. Age younger than 36 years was an unfavorable prognostic factor, and patients with metastases at diagnosis had poorer survival. Histological subtypes were pineoblastoma in 21 patients, pineocytoma in 8 patients, and pineocytoma with intermediate differentiation in 6 patients.[4]

In a study of medical records of 31 patients with pineoblastoma (female, 67.7%; median age, 18.2 yr), median overall survival was found to be 8.7 years, with 2-, 5-, and 10- year actuarial rates of 89.5%, 69.4%, and 48.6%, respectively. Median disease-free survival was 10 years, with 2-, 5-, and 10- year actuarial rates of 84.3%, 62.6%, and 55.7%.[5]

In another study of patients with pineoblastoma, the overall survival rate was 54% (175 of 299 patients) at a mean follow-up of 31 ± 1.9 months (range, 1-159 months). A markedly worse prognosis was demonstrated for children aged 5 years or younger compared with older patients (5-year survival rate: 15% for children aged ≤ 5 yr vs 57% for children aged ≥ 5 yr). A failure to achieve gross total resection markedly worsened patient survival.[6]

Previous
 
 
Contributor Information and Disclosures
Author

Jeffrey N Bruce, MD Edgar M Housepian Professor of Neurological Surgery Research, Vice-Chairman and Professor of Neurological Surgery, Director of Brain Tumor Tissue Bank, Director of Bartoli Brain Tumor Laboratory, Department of Neurosurgery, Columbia University College of Physicians and Surgeons

Jeffrey N Bruce, MD is a member of the following medical societies: Alpha Omega Alpha, American Association for the Advancement of Science, American Association of Neurological Surgeons, New York Academy of Sciences, North American Skull Base Society, Society of Neurological Surgeons, Society for Neuro-Oncology, American Society of Clinical Oncology, Congress of Neurological Surgeons, Pituitary Society

Disclosure: Received grant/research funds from NIH for other.

Coauthor(s)

Richard CE Anderson, MD Assistant Professor of Neurosurgery and Pediatric Neurosurgery, Columbia University Medical Center, Columbia University College of Physicians and Surgeons; Director, Pediatric Neurosurgery, St Joseph's Children's Hospital

Richard CE Anderson, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Surgeons, Congress of Neurological Surgeons, American Association of Neurological Surgeons, Phi Beta Kappa

Disclosure: Nothing to disclose.

Alfred T Ogden, MD Assistant Professor, Department of Neurological Surgery, Columbia University Medical Center

Alfred T Ogden, MD is a member of the following medical societies: Alpha Omega Alpha, American Association of Neurological Surgeons, Congress of Neurological Surgeons

Disclosure: Nothing to disclose.

Benjamin Kennedy, MD Columbia University College of Physicians and Surgeons

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Brian H Kopell, MD Associate Professor, Department of Neurosurgery, Icahn School of Medicine at Mount Sinai

Brian H Kopell, MD is a member of the following medical societies: Alpha Omega Alpha, American Association of Neurological Surgeons, International Parkinson and Movement Disorder Society, Congress of Neurological Surgeons, American Society for Stereotactic and Functional Neurosurgery, North American Neuromodulation Society

Disclosure: Received consulting fee from Medtronic for consulting; Received consulting fee from St Jude Neuromodulation for consulting; Received consulting fee from MRI Interventions for consulting.

Additional Contributors

Michael G Nosko, MD, PhD Associate Professor of Surgery, Chief, Division of Neurosurgery, Medical Director, Neuroscience Unit, Medical Director, Neurosurgical Intensive Care Unit, Director, Neurovascular Surgery, Rutgers Robert Wood Johnson Medical School

Michael G Nosko, MD, PhD is a member of the following medical societies: Academy of Medicine of New Jersey, Congress of Neurological Surgeons, Canadian Neurological Sciences Federation, Alpha Omega Alpha, American Association of Neurological Surgeons, American College of Surgeons, American Heart Association, American Medical Association, New York Academy of Sciences, Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors Andrew T Parsa, MD, PhD, and Chris E Mandigo, MD.

References
  1. Van Wagenen WP. A surgical approach for removal of certain pineal tumors: Report of a case. Surg Gynecol Obstet. 1931. 53:216.

  2. Torkildsen A. Should extirpation be attempted in cases of neoplasms in or near the third ventricle of the brain? Experiences with a palliative method. Journal of Neurosurgery. 1948. 5:269.

  3. Ringertz N, Nordenstam H, Flyger G. Tumors of the pineal region. J Neuropathol Exp Neurol. 1954 Oct. 13(4):540-61. [Medline].

  4. Villà S, Miller RC, Krengli M, Abusaris H, Baumert BG, Servagi-Vernat S, et al. Primary pineal tumors: outcome and prognostic factors--a study from the Rare Cancer Network (RCN). Clin Transl Oncol. 2012 Nov. 14 (11):827-34. [Medline].

  5. Farnia B, Allen PK, Brown PD, Khatua S, Levine NB, Li J, et al. Clinical outcomes and patterns of failure in pineoblastoma: a 30-year, single-institution retrospective review. World Neurosurg. 2014 Dec. 82 (6):1232-41. [Medline].

  6. Tate M, Sughrue ME, Rutkowski MJ, Kane AJ, Aranda D, McClinton L, et al. The long-term postsurgical prognosis of patients with pineoblastoma. Cancer. 2012 Jan 1. 118 (1):173-9. [Medline].

  7. Choudhri AF, Whitehead MT, Siddiqui A, Klimo P Jr, Boop FA. Diffusion characteristics of pediatric pineal tumors. Neuroradiol J. 2015 Apr. 28 (2):209-16. [Medline].

  8. Al-Holou WN, Terman SW, Kilburg C, Garton HJ, Muraszko KM, Chandler WF, et al. Prevalence and natural history of pineal cysts in adults. J Neurosurg. 2011 Dec. 115(6):1106-14. [Medline].

  9. Russell DS, Rubinstein LJ. Tumours and tumour-like lesions of maldevelopmental origin. Russel DS, Rubenstein LJ, eds. Pathology of tumours of the nervous sys. Baltimore, Md: Williams & Wilkins; 1989. 664-765.

  10. Ashley DM, Longee D, Tien R, et al. Treatment of patients with pineoblastoma with high dose cyclophosphamide. Med Pediatr Oncol. 1996 Jun. 26(6):387-92. [Medline].

  11. Fuller BG, Kapp DS, Cox R. Radiation therapy of pineal region tumors: 25 new cases and a review of 208 previously reported cases. Int J Radiat Oncol Biol Phys. 1994 Jan 1. 28(1):229-45. [Medline].

  12. Manera L, Regis J, Chinot O, et al. Pineal region tumors: the role of stereotactic radiosurgery. Stereotact Funct Neurosurg. 1996. 66 Suppl 1:164-73. [Medline].

  13. Regis J, Bouillot P, Rouby-Volot F, et al. Pineal region tumors and the role of stereotactic biopsy: review of the mortality, morbidity, and diagnostic rates in 370 cases. Neurosurgery. 1996 Nov. 39(5):907-12; discussion 912-4. [Medline].

  14. Kreth FW, Schätz CR, Pagenstecher A, et al. Stereotactic management of lesions of the pineal region. Neurosurgery. 1996 Aug. 39(2):280-9; discussion 289-91. [Medline].

  15. Ferrer E, Santamarta D, Garcia-Fructuoso G, et al. Neuroendoscopic management of pineal region tumours. Acta Neurochir (Wien). 1997. 139(1):12-20; discussion 20-1. [Medline].

  16. Pople IK, Athanasiou TC, Sandeman DR, Coakham HB. The role of endoscopic biopsy and third ventriculostomy in the management of pineal region tumours. Br J Neurosurg. 2001 Aug. 15(4):305-11. [Medline].

  17. Gangemi M, Maiuri F, Colella G, Buonamassa S. Endoscopic surgery for pineal region tumors. Minim Invasive Neurosurg. 2001 Jun. 44(2):70-3. [Medline].

  18. Oi S, Kamio M, Joki T, Abe T. Neuroendoscopic anatomy and surgery in pineal region tumors: role of neuroendoscopic procedure in the 'minimally-invasive preferential' management. J Neurooncol. 2001 Sep. 54(3):277-86. [Medline].

  19. Choi JU, Kim DS, Chung SS, et al. Treatment of germ cell tumors in the pineal region. Childs Nerv Syst. 1998 Jan-Feb. 14(1-2):41-8. [Medline].

  20. Sawamura Y, de Tribolet N, Ishii N, et al. Management of primary intracranial germinomas: diagnostic surgery or radical resection?. J Neurosurg. 1997 Aug. 87(2):262-6. [Medline].

  21. Dandy WE. Operative experience in cases of pineal tumor. Archives of Surgery. 1936. 33:19-46.

  22. Stein BM, Bruce JN. Surgical management of pineal region tumors (honored guest lecture). Clin Neurosurg. 1992. 39:509-32. [Medline].

  23. Ahmed SR, Shalet SM, Price DA, Pearson D. Human chorionic gonadotrophin secreting pineal germinoma and precocious puberty. Arch Dis Child. 1983 Sep. 58(9):743-5. [Medline]. [Full Text].

  24. Allen JC, Nisselbaum J, Epstein F, et al. Alphafetoprotein and human chorionic gonadotropin determination in cerebrospinal fluid. An aid to the diagnosis and management of intracranial germ-cell tumors. J Neurosurg. 1979 Sep. 51(3):368-74. [Medline].

  25. Anan M, Ishii K, Nakamura T, Yamashita M, Katayama S, Sainoo M, et al. Postoperative adjuvant treatment for pineal parenchymal tumour of intermediate differentiation. J Clin Neurosci. 2006 Nov. 13(9):965-8. [Medline].

  26. Aoyama H. Radiation therapy for intracranial germ cell tumors. Prog Neurol Surg. 2009. 23:96-105. [Medline].

  27. Bendersky M, Lewis M, Mandelbaum DE, et al. Serial neuropsychological follow-up of a child following craniospinal irradiation. Dev Med Child Neurol. 1988 Dec. 30(6):816-20. [Medline].

  28. Bjornsson J, Scheithauer BW, Okazaki H, et al. Intracranial germ cell tumors: pathobiological and immunohistochemical aspects of 70 cases. J Neuropathol Exp Neurol. 1985 Jan. 44(1):32-46. [Medline].

  29. Borit A. History of tumors of the pineal region. Am J Surg Pathol. 1981 Sep. 5(6):613-20. [Medline].

  30. Brownstein S, de Chadarévian JP, Little JM. Trilateral retinoblastoma. Report of two cases. Arch Ophthalmol. 1984 Feb. 102(2):257-62. [Medline].

  31. Bruce DA, Allen JC. Tumor staging for pineal region tumors of childhood. Cancer. 1985 Oct 1. 56(7 Suppl):1792-4. [Medline].

  32. Bruce J, Stein B. Supracerebellar approaches in the pineal region. Apuzzo M, ed. Brain Surgery: Complication Avoidance and Management. New York, NY: Churchill Livingstone; 1993. 511-536.

  33. Bruce J, Tamarkin L, Riedel C, et al. Sequential cerebrospinal fluid and plasma sampling in humans: 24-hour melatonin measurements in normal subjects and after peripheral sympathectomy. J Clin Endocrinol Metab. 1991 Apr. 72(4):819-23. [Medline].

  34. Bruce JN, Ogden AT. Surgical strategies for treating patients with pineal region tumors. J Neurooncol. 2004 Aug-Sep. 69(1-3):221-36. [Medline].

  35. Bruce JN, Stein BM. Surgical management of pineal region tumors. Acta Neurochir (Wien). 1995. 134(3-4):130-5. [Medline].

  36. Burres KP, Hamilton RD. Pineal apoplexy. Neurosurgery. 1979 Mar. 4(3):264-8. [Medline].

  37. Calaminus G, Bamberg M, Baranzelli MC, et al. Intracranial germ cell tumors: a comprehensive update of the European data. Neuropediatrics. 1994 Feb. 25(1):26-32. [Medline].

  38. Calaminus G, Bamberg M, Jürgens H, Kortmann RD, Sörensen N, Wiestler OD, et al. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89. Klin Padiatr. 2004 May-Jun. 216(3):141-9. [Medline].

  39. Camins MB, Schlesinger EB. Treatment of tumours of the posterior part of the third ventricle and the pineal region: a long term follow-up. Acta Neurochir (Wien). 1978. 40(1-2):131-43. [Medline].

  40. Chang T, Teng MM, Guo WY, et al. CT of pineal tumors and intracranial germ-cell tumors. AJR Am J Roentgenol. 1989 Dec. 153(6):1269-74. [Medline].

  41. Chernov MF, Kamikawa S, Yamane F, Ishihara S, Kubo O, Hori T. Neurofiberscopic biopsy of tumors of the pineal region and posterior third ventricle: indications, technique, complications, and results. Neurosurgery. 2006 Aug. 59(2):267-77; discussion 267-77. [Medline].

  42. Cuccia V, Rodríguez F, Palma F, et al. Pinealoblastomas in children. Childs Nerv Syst. 2006 Jun. 22(6):577-85. [Medline].

  43. Dempsey PK, Kondziolka D, Lunsford LD. Stereotactic diagnosis and treatment of pineal region tumours and vascular malformations. Acta Neurochir (Wien). 1992. 116(1):14-22. [Medline].

  44. Deshmukh VR, Smith KA, Rekate HL, Coons S, Spetzler RF. Diagnosis and management of pineocytomas. Neurosurgery. 2004 Aug. 55(2):349-55; discussion 355-7. [Medline].

  45. Di Costanzo A, Tedeschi G, Di Salle F, Golia F, Morrone R, Bonavita V. Pineal cysts: an incidental MRI finding?. J Neurol Neurosurg Psychiatry. 1993 Feb. 56(2):207-8. [Medline]. [Full Text].

  46. Dudgeon J, Lee WR. The trilateral retinoblastoma syndrome. Trans Ophthalmol Soc U K. 1983. 103 ( Pt 5):523-9. [Medline].

  47. Edwards MS, Hudgins RJ, Wilson CB, et al. Pineal region tumors in children. J Neurosurg. 1988 May. 68(5):689-97. [Medline].

  48. Erlich SS, Apuzzo ML. The pineal gland: anatomy, physiology, and clinical significance. J Neurosurg. 1985 Sep. 63(3):321-41. [Medline].

  49. Fain JS, Tomlinson FH, Scheithauer BW, et al. Symptomatic glial cysts of the pineal gland. J Neurosurg. 1994 Mar. 80(3):454-60. [Medline].

  50. Felix I, Becker LE. Intracranial germ cell tumors in children: an immunohistochemical and electron microscopic study. Pediatr Neurosurg. 1990-1991. 16(3):156-62. [Medline].

  51. Fetell MR, Bruce JN, Burke AM, et al. Non-neoplastic pineal cysts. Neurology. 1991 Jul. 41(7):1034-40. [Medline].

  52. Fetell MR, Stein BM. Neuroendocrine aspects of pineal tumors. Neurol Clin. 1986 Nov. 4(4):877-905. [Medline].

  53. Finelli DA, Shurin SB, Bardenstein DS. Trilateral retinoblastoma: two variations. AJNR Am J Neuroradiol. 1995 Jan. 16(1):166-70. [Medline].

  54. Fleege MA, Miller GM, Fletcher GP, et al. Benign glial cysts of the pineal gland: unusual imaging characteristics with histologic correlation. AJNR Am J Neuroradiol. 1994 Jan. 15(1):161-6. [Medline].

  55. Fèvre-Montange M, Champier J, Szathmari A, Wierinckx A, Mottolese C, Guyotat J, et al. Microarray analysis reveals differential gene expression patterns in tumors of the pineal region. J Neuropathol Exp Neurol. 2006 Jul. 65(7):675-84. [Medline].

  56. Fèvre-Montange M, Hasselblatt M, Figarella-Branger D, Chauveinc L, Champier J, Saint-Pierre G, et al. Prognosis and histopathologic features in papillary tumors of the pineal region: a retrospective multicenter study of 31 cases. J Neuropathol Exp Neurol. 2006 Oct. 65(10):1004-11. [Medline].

  57. Griffin BR, Griffin TW, Tong DY, et al. Pineal region tumors: results of radiation therapy and indications for elective spinal irradiation. Int J Radiat Oncol Biol Phys. 1981 May. 7(5):605-8. [Medline].

  58. Gururangan S, McLaughlin C, Quinn J, Rich J, Reardon D, Halperin EC, et al. High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. J Clin Oncol. 2003 Jun 1. 21(11):2187-91. [Medline].

  59. Haase J, Nielsen K. Value of tumor markers in the treatment of endodermal sinus tumors and choriocarcinomas in the pineal region. Neurosurgery. 1979 Oct. 5(4):485-8. [Medline].

  60. Herrmann HD, Westphal M, Winkler K, et al. Treatment of nongerminomatous germ-cell tumors of the pineal region. Neurosurgery. 1994 Mar. 34(3):524-9; discussion 529. [Medline].

  61. Inoue HK, Naganuma H, Ono N. Pathobiology of intracranial germ-cell tumors: immunochemical, immunohistochemical, and electron microscopic investigations. J Neurooncol. 1987. 5(2):105-15. [Medline].

  62. Jakacki RI, Zeltzer PM, Boyett JM, et al. Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group. J Clin Oncol. 1995 Jun. 13(6):1377-83. [Medline].

  63. Jennings MT, Gelman R, Hochberg F. Intracranial germ-cell tumors: natural history and pathogenesis. J Neurosurg. 1985 Aug. 63(2):155-67. [Medline].

  64. Jooma R, Kendall BE. Diagnosis and management of pineal tumors. J Neurosurg. 1983 May. 58(5):654-65. [Medline].

  65. Jouvet A, Fevre-Montange M, Besançon R, et al. Structural and ultrastructural characteristics of human pineal gland, and pineal parenchymal tumors. Acta Neuropathol. 1994. 88(4):334-48. [Medline].

  66. Kang JK, Jeun SS, Hong YK, et al. Experience with pineal region tumors. Childs Nerv Syst. 1998 Jan-Feb. 14(1-2):63-8. [Medline].

  67. Klein P, Rubinstein LJ. Benign symptomatic glial cysts of the pineal gland: a report of seven cases and review of the literature. J Neurol Neurosurg Psychiatry. 1989 Aug. 52(8):991-5. [Medline]. [Full Text].

  68. Konovalov AN, Pitskhelauri DI. Principles of treatment of the pineal region tumors. Surg Neurol. 2003 Apr. 59(4):250-68. [Medline].

  69. Krabbe KH. The pineal gland, especially in relation to the problem on its supposed significance in sexual development. Endocrinology. 1923. 7:379-414.

  70. Linstadt D, Wara WM, Edwards MS, et al. Radiotherapy of primary intracranial germinomas: the case against routine craniospinal irradiation. Int J Radiat Oncol Biol Phys. 1988 Aug. 15(2):291-7. [Medline].

  71. Malogolowkin MH, Mahour GH, Krailo M, et al. Germ cell tumors in infancy and childhood: a 45-year experience. Pediatr Pathol. 1990. 10(1-2):231-41. [Medline].

  72. Matsutani M. Pineal germ cell tumors. Prog Neurol Surg. 2009. 23:76-85. [Medline].

  73. Matsutani M, Sano K, Takakura K, et al. Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg. 1997 Mar. 86(3):446-55. [Medline].

  74. Min KW, Scheithauer BW, Bauserman SC. Pineal parenchymal tumors: an ultrastructural study with prognostic implications. Ultrastruct Pathol. 1994 Jan-Apr. 18(1-2):69-85. [Medline].

  75. Müller-Forell W, Schroth G, Egan PJ. MR imaging in tumors of the pineal region. Neuroradiology. 1988. 30(3):224-31. [Medline].

  76. Neuwelt EA, Glasberg M, Frenkel E, et al. Malignant pineal region tumors. A clinico-pathological study. J Neurosurg. 1979 Nov. 51(5):597-607. [Medline].

  77. Olsen MM, Raffensperger JG, Gonzalez-Crussi F, et al. Endodermal sinus tumor: a clinical and pathological correlation. J Pediatr Surg. 1982 Dec. 17(6):832-40. [Medline].

  78. Ono N, Isobe I, Uki J, et al. Recurrence of primary intracranial germinomas after complete response with radiotherapy: recurrence patterns and therapy. Neurosurgery. 1994 Oct. 35(4):615-20; discussion 620-1. [Medline].

  79. Packer RJ, Sutton LN, Rorke LB, et al. Intracranial embryonal cell carcinoma. Cancer. 1984 Aug 1. 54(3):520-4. [Medline].

  80. Packer RJ, Sutton LN, Rosenstock JG, et al. Pineal region tumors of childhood. Pediatrics. 1984 Jul. 74(1):97-102. [Medline].

  81. Parwani AV, Baisden BL, Erozan YS, et al. Pineal gland lesions: a cytopathologic study of 20 specimens. Cancer. 2005 Apr 25. 105(2):80-6. [Medline].

  82. Posner M, Horrax G. Eye signs in pineal tumors. Journal of Neurosurgery. 1946. 3:15-24.

  83. Quest DO, Kleriga E. Microsurgical anatomy of the pineal region. Neurosurgery. 1980 Apr. 6(4):385-90. [Medline].

  84. Radovanovic I, Dizdarevic K, de Tribolet N, Masic T, Muminagic S. Pineal region tumors--neurosurgical review. Med Arh. 2009. 63(3):171-3. [Medline].

  85. Robertson PL, DaRosso RC, Allen JC. Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy. J Neurooncol. 1997 Mar. 32(1):71-80. [Medline].

  86. Robinson S, Cohen AR. The role of neuroendoscopy in the treatment of pineal region tumors. Surg Neurol. 1997 Oct. 48(4):360-5; discussion 365-7. [Medline].

  87. Salzman KL, Rojiani AM, Buatti J, et al. Primary intracranial germ cell tumors: clinicopathologic review of 32 cases. Pediatr Pathol Lab Med. 1997 Sep-Oct. 17(5):713-27. [Medline].

  88. Sato K, Takeuchi H, Kubota T. Pathology of intracranial germ cell tumors. Prog Neurol Surg. 2009. 23:59-75. [Medline].

  89. Schild SE, Scheithauer BW, Schomberg PJ, et al. Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects. Cancer. 1993 Aug 1. 72(3):870-80. [Medline].

  90. Shinoda J, Miwa Y, Sakai N, et al. Immunohistochemical study of placental alkaline phosphatase in primary intracranial germ-cell tumors. J Neurosurg. 1985 Nov. 63(5):733-9. [Medline].

  91. Silvani A, Eoli M, Salmaggi A, Lamperti E, Fariselli L, Milanesi I, et al. Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: a single-institution study. J Neurooncol. 2005 Feb. 71(3):271-6. [Medline].

  92. Smirniotopoulos JG, Rushing EJ, Mena H. Pineal region masses: differential diagnosis. Radiographics. 1992 May. 12(3):577-96. [Medline].

  93. Stein BM. The infratentorial supracerebellar approach to pineal lesions. J Neurosurg. 1971 Aug. 35(2):197-202. [Medline].

  94. Steinbok P, Dolman CL, Kaan K. Pineocytomas presenting as subarachnoid hemorrhage. Report of two cases. J Neurosurg. 1977 Nov. 47(5):776-80. [Medline].

  95. Steno J, Bizik I, Biksadsky P. Pineal region teratomas in children. Ann N Y Acad Sci. 1997 Sep 17. 824:241-4. [Medline].

  96. Ueki K, Tanaka R. Treatments and prognoses of pineal tumors--experience of 110 cases. Neurol Med Chir (Tokyo). 1980 Jan. 20(1):1-26. [Medline].

  97. Villano JL, Propp JM, Porter KR, Stewart AK, Valyi-Nagy T, Li X, et al. Malignant pineal germ-cell tumors: an analysis of cases from three tumor registries. Neuro Oncol. 2008 Apr. 10(2):121-30. [Medline]. [Full Text].

  98. Yamashita J, Handa H. Diagnosis and treatment of pineal tumours. Kyoto University experience (1941-1984). Acta Neurochir Suppl (Wien). 1988. 42:137-41. [Medline].

  99. Yamini B, Refai D, Rubin CM, Frim DM. Initial endoscopic management of pineal region tumors and associated hydrocephalus: clinical series and literature review. J Neurosurg. 2004 May. 100(5 Suppl Pediatrics):437-41. [Medline].

  100. Yoshida J, Sugita K, Kobayashi T, et al. Prognosis of intracranial germ cell tumours: effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16). Acta Neurochir (Wien). 1993. 120(3-4):111-7. [Medline].

 
Previous
Next
 
Gadolinium-enhanced MRI of a 33-year-old woman who presented with visual loss, amenorrhea, and diabetes insipidus. MRI shows germinomatous invasion of the pineal gland (large arrowhead), optic chiasm (long arrow), pituitary stalk (small arrowhead), and floor of the third ventricle (short arrow).
Noncontrast MRI of a pineocytoma in a 40-year-old man presenting with acute hydrocephalus. At surgery, the high signal area (arrow) turned out to be acute hemorrhage.
MRI of a 21-year-old man with a germinoma in the pineal region. This T1-weighted noncontrast sagittal scan shows isointense tumor, which has obstructed the aqueduct of Sylvius (arrow) to cause hydrocephalus.
MRI of a 21-year-old man with a germinoma in the pineal region. This T2-weighted noncontrast axial scan shows the tumor as hyperintense to brain matter but hypointense to cerebrospinal fluid (CSF).
MRI of a 21-year-old man with a germinoma in the pineal region. Homogenous gadolinium enhancement of the tumor is demonstrated on this T1-weighted contrast-enhancing sagittal scan.
Sagittal MRI of a heterogeneous mixed germ cell tumor of the pineal region in a 21-year-old man who presented with hydrocephalus. After pathologic examination following complete surgical resection, the tumor was found to have multiple components, including endodermal sinus tumor, embryonal cell carcinoma, immature teratoma, and mature teratoma.
Gross tissue specimens were obtained from a 21-year-old man who presented with hydrocephalus. After pathologic examination following complete surgical resection, the tumor was found to have multiple components, including endodermal sinus tumor, embryonal cell carcinoma, immature teratoma, and mature teratoma. Gross tissue specimens reflect heterogeneity of various germ cell components.
T1-weighted contrast-enhancing sagittal MRI from a 41-year-old man with a pineocytoma. The tumor enhances homogeneously with gadolinium, except for a cystic portion.
Micrograph from a mature teratoma of the pineal region that consists of well-differentiated tissue from all 3 germinal layers. This image demonstrates nonkeratinizing squamous cell epithelium alternating with areas of ciliated columnar epithelium.
This micrograph demonstrates osteoid bone with surrounding periosteal tissue and mesenchymal stroma occurring within a mature teratoma of the pineal region.
This micrograph features cartilaginous tissue observed within a mature teratoma of the pineal region.
Immature teratoma of the pineal region with highly cellular primitive elements resembling fetal neural tube structure.
Endodermal sinus tumor with a characteristic Schiller-Duval body.
Pineoblastoma composed of highly cellular, poorly differentiated cells that form patternless sheets.
Pineocytoma consisting of benign well-differentiated cells forming rosettes.
MRI of a 44-year-old woman 10 years after resection of a mixed pineal cell tumor. The tumor has recurred in the pineal region (arrow) and has seeded the fourth ventricle (arrowheads).
The right side of this image demonstrates 3 operative approaches to the pineal region. The appropriate patient positioning for each approach is on the left. Number 1 is the supracerebellar-infratentorial approach, number 2 is the occipital-transtentorial approach, and number 3 is the parietal-interhemispheric approach.
The left drawing is a sagittal view of a patient with a pineal region tumor. The right drawing shows a sagittal view of the supracerebellar/infratentorial approach to the pineal region.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.